Genetic variants in BCMO1 and CD36 are associated with plasma lutein concentrations and macular pigment optical density in humans

Annals of Medicine

Volumn 43, Issue 1, 2011, Pages 47-59

  Borel, Patrick ^a,b,c   De Edelenyi, Fabien Szabo ^a,b,c   Vincent Baudry, Stéphanie ^d   Malezet Desmoulin, Christiane ^a,b,c   Margotat, Alain ^a,b,c   Lyan, Bernard ^e   Gorrand, Jean Marie ^f   Meunier, Nathalie ^e   Drouault Holowacz, Sophie ^d   Bieuvelet, Severine ^d  

^a INSERM   (France)

^b INSERM   (France)

^c AIX MARSEILLE UNIVERSITY   (France)

^d Pileje   (France)

^e CRNH AUVERGNE   (France)

^f UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Age related macular degeneration; bioavailability; carotenoids; eye; genetic polymorphisms; genetic variant; nutrition; retina; xanthophylls

Indexed keywords

ABC TRANSPORTER A1; BETA CAROTENE DIOXYGENASE 2; BETA CAROTENE MONOXYGENASE1; CD36 ANTIGEN; PLACEBO; PROTEIN ABCG8; PROTEIN NPC1L1; SCAVENGER RECEPTOR BI; UNCLASSIFIED DRUG; XANTHOPHYLL;

ADULT; ARTICLE; COHORT ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; EXON; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; INTRON; MACULAR PIGMENT OPTICAL DENSITY; MAJOR CLINICAL STUDY; MALE; OBSERVATIONAL STUDY; OPTICAL DENSITY; PARTIAL LEAST SQUARES REGRESSION; PRIORITY JOURNAL; RETINA MACULA AGE RELATED DEGENERATION; RETINA MACULA LUTEA; SINGLE NUCLEOTIDE POLYMORPHISM; UNIVARIATE ANALYSIS; VITAMIN SUPPLEMENTATION;

ANTIGENS, CD36; BETA-CAROTENE 15,15'-MONOOXYGENASE; CARRIER PROTEINS; DIETARY SUPPLEMENTS; GENETIC VARIATION; HUMANS; LUTEIN; MACULAR DEGENERATION; MALE; MIDDLE AGED; OXYGENASES; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 78651387052     PISSN: 07853890     EISSN: 13652060     Source Type: Journal    
DOI: 10.3109/07853890.2010.531757     Document Type: Article

References (59)

1. Evans JR. Risk factors for age-related macular degeneration. Prog Retin Eye Res. 2001;20:227-53.
2. Krinsky NI, Landrum JT, Bone RA. Biologic mechanisms of the protective role of lutein and zeaxanthin in the eye. Annu Rev Nutr. 2003;23:171-201.
3. Landrum JT, Bone RA. Lutein, zeaxanthin, and the macular pigment. Arch Biochem Biophys. 2001;385:28-40.
4. Johnson EJ, Neuringer M, Russell RM, Schalch W, Snodderly DM. Nutritional manipulation of primate retinas, III: Effects of lutein or zeaxanthin supplementation on adipose tissue and retina of xanthophyll-free monkeys. Invest Ophthalmol Vis Sci. 2005;46:692-702.
5. Tyssandier V, Reboul E, Dumas JF, Bouteloup-Demange C, Armand M, Marcand J, et al. Processing of vegetable-borne carotenoids in the human stomach and duodenum. Am J Physiol Gastrointest Liver Physiol. 2003;284:G913-23.
6. Reboul E, Richelle M, Perrot E, Desmoulins-Malezet C, Pirisi V, Borel P. Bioaccessibility of carotenoids and vitamin E from their main dietary sources. J Agric Food Chem. 2006; 54:8749-55.
7. Borel P, Grolier P, Armand M, Partier A, Lafont H, Lairon D, et al. Carotenoids in biological emulsions: solubility, surface-to-core distribution, and release from lipid droplets. J Lipid Res. 1996;37:250-61.
8. Tyssandier V, Lyan B, Borel P. Main factors governing the transfer of carotenoids from emulsion lipid droplets to micelles. Biochim Biophys Acta. 2001;1533:285-92.
9. Borel P. Factors affecting intestinal absorption of highly lipophilic food microconstituents (fat-soluble vitamins, caro-tenoids and phytosterols). Clin Chem Lab Med. 2003;41: 979-94.
10. Hollander D, Muralidhara KS. Vitamin A1 intestinal absorption in vivo: influence of luminal factors on transport. Am J Physiol Gastrointest Liver Physiol. 1977;232:E471-7.
11. Hollander D. Intestinal absorption of vitamin A, E, D, and K. J Lab Clin Med. 1981;97:449-62.
12. Hollander D, Ruble PE. beta-carotene intestinal absorption: bile, fatty acid, pH, and flow rate effects on transport. Am J Physiol. 1978;235:E686-91.
13. Reboul E, Abou L, Mikail C, Ghiringhelli O, Andre M, Portugal H, et al. Lutein transport by Caco-2 TC-7 cells occurs partly by a facilitated process involving the scavenger receptor class B type I (SR-BI). Biochem J. 2005;387(Pt 2): 455-61.
14. van Bennekum A, Werder M, Thuahnai ST, Han CH, Duong P, Williams DL, et al. Class B scavenger receptor-mediated intestinal absorption of dietary beta-carotene and cholesterol. Biochemistry. 2005;44:4517-25.
15. During A, Dawson HD, Harrison EH. Carotenoid transport is decreased and expression of the lipid transporters SR-BI, NPC1L1, and ABCA1 is downregulated in Caco-2 cells treated with ezetimibe. J Nutr. 2005;135:2305-12.
16. During A, Harrison EH. Mechanisms of provitamin A (carotenoid) and vitamin A (retinol) transport into and out of intestinal Caco-2 cells. J Lipid Res. 2007;48:2283-94.
17. Moussa M, Landrier JF, Reboul E, Ghiringhelli O, Comera C, Collet X, et al. Lycopene absorption in human intestinal cells and in mice involves scavenger receptor class B type I but not niemann-pick C1-like 1. J Nutr. 2008;138:1432-6.
18. Davis HR Jr, Zhu LJ, Hoos LM, Tetzloff G, Maguire M, Liu J, et al. Niemann-Pick C1 Like 1 (NPC1L1) is the intestinal phytosterol and cholesterol transporter and a key modulator of whole-body cholesterol homeostasis. J Biol Chem. 2004;279:33586-92.
19. Narushima K, Takada T, Yamanashi Y, Suzuki H. Niemann-pick C1-like 1 mediates alpha-tocopherol transport. Mol Pharmacol. 2008;74:42-9.
20. Reboul E, Klein A, Bietrix F, Gleize B, Malezet-Desmoulins C, Schneider M, et al. Scavenger receptor class B type I (SR-BI) is involved in vitamin E transport across the ente-rocyte. J Biol Chem. 2006;281:4739-45.
21. Lee MH, Lu K, Patel SB. Genetic basis of sitosterolemia. Curr Opin Lipidol. 2001;12:141-9.
22. Oram JF. Tangier disease and ABCA1. Biochim Biophys Acta. 2000;1529:321-30.
23. Oram JF, Vaughan AM, Stocker R. ATP-binding cassette transporter A1 mediates cellular secretion of alpha-tocopherol. J Biol Chem. 2001;276:39898-902.
24. Reboul E, Trompier D, Moussa M, Klein A, Landrier JF, Chimini G, et al. ATP-binding cassette transporter A1 is signifi cantly involved in the intestinal absorption of alpha-and gamma-tocopherol but not in that of retinyl palmitate in mice. Am J Clin Nutr. 2009;89:177-84.
25. Tyssandier V, Choubert G, Grolier P, Borel P. Carotenoids, mostly the xanthophylls, exchange between plasma lipopro-teins. Int J Vitam Nutr Res. 2002;72:300-8.
26. Borel P, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-Baudry S, et al. Human plasma levels of vitamin E and caro-tenoids are associated with genetic polymorphisms in genes involved in lipid metabolism. J Nutr. 2007;137:2653-9.
27. Borel P, Moussa M, Reboul E, Lyan B, Defoort C, Vincent-Baudry S, et al. Human fasting plasma concentrations of vitamin E and carotenoids, and their association with genetic variants in apo C-III, cholesteryl ester transfer protein, hepatic lipase, intestinal fatty acid binding protein and microsomal triacylglycerol transfer protein. Br J Nutr. 2009; 101:680-7.
28. During A, Doraiswamy S, Harrison EH. Xanthophylls are preferentially taken up compared with beta-carotene by retinal cells via a SRBI-dependent mechanism. J Lipid Res. 2008;49:1715-24.
29. von Lintig J, Vogt K. Vitamin A formation in animals: molecular identifi cation and functional characterization of carotene cleaving enzymes. J Nutr. 2004;134:251S-6S.
30. Vage DI, Boman IA. A nonsense mutation in the beta-carotene oxygenase 2 (BCO2) gene is tightly associated with accumulation of carotenoids in adipose tissue in sheep (Ovis aries). BMC Genet. 2010;11:10.
31. Hercberg S, Deheeger M, Preziosi P. SU.VI.MAX: Portions alimentaires. Manuel photos pour l'estimation des quantités. SU.VI.MAX. Economica ed. Paris: 2002. Portions alimen-taires-Manuel photos pour l'estimation des quantités.
32. Chug-Ahuja JK, Holden JM, Forman MR, Mangels AR, Beecher GR, Lanza E. The development and application of a carotenoid database for fruits, vegetables, and selected multicomponent foods. J Am Diet Assoc. 1993;93: 318-23.
33. Cardinault N, Tyssandier V, Grolier P, Winklhofer-Roob BM, Ribalta J, Bouteloup-Demange C, et al. Comparison of the postprandial chylomicron carotenoid responses in young and older subjects. Eur J Nutr. 2003;42:315-23.
34. Tyssandier V, Feillet-Coudray C, Caris-Veyrat C, Guilland JC, Coudray C, Bureau S, et al. Effect of tomato product consumption on the plasma status of antioxidant microcon-stituents and on the plasma total antioxidant capacity in healthy subjects. J Am Coll Nutr. 2004;23:148-56.
35. Caris-Veyrat C, Amiot MJ, Tyssandier V, Grasselly D, Buret M, Mikolajczak M, et al. Influence of organic versus conventional agricultural practice on the antioxidant micro-constituent content of tomatoes and derived purees; consequences on antioxidant plasma status in humans. J Agric Food Chem. 2004;52:6503-9.
36. Curran-Celentano J, Hammond BR Jr, Ciulla TA, Cooper DA, Pratt LM, Danis RB. Relation between dietary intake, serum concentrations, and retinal concentrations of lutein and zeaxanthin in adults in a Midwest population. Am J Clin Nutr. 2001;74:796-802.
37. De la Vega FM, Lazaruk KD, Rhodes MD, Wenz MH. Assessment of two flexible and compatible SNP genotyping platforms: TaqMan SNP Genotyping Assays and the SNPlex Genotyping System. Mutat Res. 2005;573:111-35.
38. Tobler AR, Short S, Andersen MR, Paner TM, Briggs JC, Lambert SM, et al. The SNPlex genotyping system: a flexible and scalable platform for SNP genotyping. J Biomol Tech. 2005;16:398-406.
39. Zagers NPA, van Norren D. Absorption of the eye lens and macular pigment derived from the reflectance of cone photoreceptors. J Opt Soc Am. 2004;21:2257-68 .
40. van de Kraats J, van Norren D. Directional and nondirec-tional spectral reflection from the human fovea. J Biomed Opt. 2008;13:024010.
41. Lyan B, Azais-Braesco V, Cardinault N, Tyssandier V, Borel P, Alexandre-Gouabau MC, et al. Simple method for clinical determination of 13 carotenoids in human plasma using an isocratic high-performance liquid chromatographic method. J Chromatogr B Biomed Appl. 2001;751:297-303.
42. Hercberg S, Galan P, Preziosi P, Bertrais S, Mennen L, Malvy D, et al. The SU.VI.MAX Study: a randomized, placebo-controlled trial of the health effects of antioxi-dant vitamins and minerals. Arch Intern Med. 2004;164: 2335-42.
43. Tregouet DA, Escolano S, Tiret L, Mallet A, Golmard JL. A new algorithm for haplotype-based association analysis: the Stochastic-EM algorithm. Ann Hum Genet. 2004;68(Pt 2): 165-77.
44. Johnson EJ, Chung HY, Caldarella SM, Snodderly DM. The influence of supplemental lutein and docosahexaenoic acid on serum, lipoproteins, and macular pigmentation. Am J Clin Nutr. 2008;87:1521-9.
45. Richer S, Stiles W, Statkute L, Pulido J, Frankowski J, Rudy D, et al. Double-masked, placebo-controlled, randomized trial of lutein and antioxidant supplementation in the intervention of atrophic age-related macular degeneration: the Veterans LAST study (Lutein Antioxidant Supplementation Trial). Optometry. 2004;75:216-30.
46. Bone RA, Landrum JT, Guerra LH, Ruiz CA. Lutein and zeaxanthin dietary supplements raise macular pigment density and serum concentrations of these carotenoids in humans. J Nutr. 2003;133:992-8.
47. Riso P, Brusamolino A, Ciappellano S, Porrini M. Comparison of lutein bioavailability from vegetables and supplement. Int J Vitam Nutr Res. 2003;73:201-5.
48. Chung HY, Rasmussen HM, Johnson EJ. Lutein bio-availability is higher from lutein-enriched eggs than from supplements and spinach in men. J Nutr. 2004;134: 1887-93.
49. Cardinault N, Gorrand JM, Tyssandier V, Grolier P, Rock E, Borel P. Short-term supplementation with lutein affects biomarkers of lutein status similarly in young and elderly subjects. Exp Gerontol. 2003;38:573-82.
50. Broekmans WM, Berendschot TT, Klopping-Ketelaars IA, de Vries AJ, Goldbohm RA, Tijburg LB, et al. Macular pigment density in relation to serum and adipose tissue concentrations of lutein and serum concentrations of zeax-anthin. Am J Clin Nutr. 2002;76:595-603.
51. Johnson EJ, Hammond BR, Yeum KJ, Qin J, Wang XD, Castaneda C, et al. Relation among serum and tissue concentrations of lutein and zeaxanthin and macular pigment density. Am J Clin Nutr. 2000;71:1555-62.
52. Bone RA, Landrum JT, Dixon Z, Chen Y, Llerena CM. Lutein and zeaxanthin in the eyes, serum and diet of human subjects. Exp Eye Res. 2000;71:239-45.
53. Richer S, Devenport J, Lang JC. LAST II: Differential temporal responses of macular pigment optical density in patients with atrophic age-related macular degeneration to dietary supplementation with xanthophylls. Optometry. 2007; 78:213-9.
54. Ferrucci L, Perry JR, Matteini A, Perola M, Tanaka T, Silander K, et al. Common variation in the beta-carotene 15,15'-monooxygenase 1 gene affects circulating levels of carotenoids: a genome-wide association study. Am J Hum Genet. 2009;84:123-33.
55. Grolier P, Duszka C, Borel P, Alexandre-Gouabau MC, Azais-Braesco V. In vitro and in vivo inhibition of beta-carotene dioxygenase activity by canthaxanthin in rat intestine. Arch Biochem Biophys. 1997;348:233-8.
56. Langmann T, Liebisch G, Moehle C, Schifferer R, Dayoub R, Heiduczek S, et al. Gene expression profi ling identifi es retin-oids as potent inducers of macrophage lipid efflux. Biochim Biophys Acta. 2005;1740:155-61.
57. Leung WC, Hessel S, Meplan C, Flint J, Oberhauser V, Tourniaire F, et al. Two common single nucleotide polymorphisms in the gene encoding beta-carotene 15,15'-monoxygenase alter beta-carotene metabolism in female volunteers. FASEB J. 2009;23:1041-53.
58. West M, Greason E, Kolmakova A, Jahangiri A, Asztalos B, Pollin TI, et al. Scavenger receptor class B type I protein as an independent predictor of high-density lipoprotein cholesterol levels in subjects with hyperalphalipoproteinemia. J Clin Endocrinol Metab. 2009;94:1451-7.
59. Constantineau J, Greason E, West M, Filbin M, Kieft JS, Carletti MZ, et al. A synonymous variant in scavenger receptor, class B, type I gene is associated with lower SR-BI protein expression and function. Atherosclerosis. 2010;210: 177-82.